Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance

Verdelho Machado M.

首页> 外文期刊>GE jornal portugues de gastrenterologia. >Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance

【24h】

Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance

机译：控制衰减参数作为一种无创方法来检测和量化慢性肝病中的肝脂肪变性：临床意义是什么

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《GE jornal portugues de gastrenterologia.》 |2017年第4期|共4页
作者
Verdelho Machado M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease [J] . Andrade P., Rodrigues S., Rodrigues-Pinto E., GE jornal portugues de gastrenterologia. . 2017,第4期

机译：慢性肝病患者检测肝脂肪变性的控制衰减参数的诊断准确性
2. Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease [J] . Lee Sol Jae, Kim Seung Up Expert review of gastroenterology & hepatology . 2019,第1a6期

机译：非酒精性脂肪肝病患者控制衰减参数和磁共振成像 - 质子密度脂肪分数的非侵袭性监测
3. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. [J] . Sasso M, Beaugrand M, de Ledinghen V, Ultrasound in Medicine and Biology . 2010,第11期

机译：受控衰减参数（CAP）：一种用于肝脂肪变性评估的新型VCTE引导的超声衰减测量：在各种原因的慢性肝病患者队列中的初步研究和验证。
4. Influence of heterogeneities on ultrasound attenuation for liver steatosis evaluation (CAP#x2122;): Relevance of a liver guidance tool [C] . Audiere S., Clet M., Sasso M., IEEE International Ultrasonics Symposium . 2013

机译：异质性对超声衰减对肝脂肪变性评估（CAP™）的影响：肝引导工具的相关性
5. AAV9-Mediated (Pro)Renin Receptor Antagonism Reduces High Fat Diet Induced Hyperglycemia and Hepatic Steatosis in Mouse Model of Non-Alcoholic Fatty Liver Disease [D] . Afrin, Sanzida. 2020

机译：AAV9介导（Pro）肾素受体拮抗作用降低了高脂肪饮食的非酒精脂肪肝病小鼠模型中的高脂肪饮食和肝脏脂肪变性
6. Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance? [O] . Mariana Verdelho Machado 2017

机译：控制衰减参数作为一种无创方法来检测和量化慢性肝病中的肝脂肪变性：临床意义是什么？
7. Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance [O] . Mariana Verdelho Machado 2017

机译：控制衰减参数作为检测和量化慢性肝病肝脏脂肪变性的无创方法：临床相关性是什么

Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance

著录项

相似文献

相关主题

期刊订阅